Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4797132
Max Phase: Preclinical
Molecular Formula: C24H27N5O4
Molecular Weight: 449.51
Molecule Type: Unknown
Associated Items:
ID: ALA4797132
Max Phase: Preclinical
Molecular Formula: C24H27N5O4
Molecular Weight: 449.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(Cn1nnc2cc(C#Cc3ccc(CN4CCOCC4)cc3)ccc21)N(O)C=O
Standard InChI: InChI=1S/C24H27N5O4/c1-2-33-24(29(31)18-30)17-28-23-10-9-20(15-22(23)25-26-28)6-3-19-4-7-21(8-5-19)16-27-11-13-32-14-12-27/h4-5,7-10,15,18,24,31H,2,11-14,16-17H2,1H3
Standard InChI Key: PSFFZWFVRXKHSW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 449.51 | Molecular Weight (Monoisotopic): 449.2063 | AlogP: 1.87 | #Rotatable Bonds: 8 |
Polar Surface Area: 92.95 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.60 | CX Basic pKa: 6.70 | CX LogP: 2.56 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.18 | Np Likeness Score: -1.39 |
1. Furuya T,Shapiro AB,Comita-Prevoir J,Kuenstner EJ,Zhang J,Ribe SD,Chen A,Hines D,Moussa SH,Carter NM,Sylvester MA,Romero JAC,Vega CV,Sacco MD,Chen Y,O'Donnell JP,Durand-Reville TF,Miller AA,Tommasi RA. (2020) N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay., 28 (24): [PMID:33160146] [10.1016/j.bmc.2020.115826] |
Source(1):